Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Unraveling targetable protease networks in tumour and stroma subtypes of pancreatic cancer
EF 2020-21
Résumé
Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer. One major characteristic of PDAC is the stroma, or the tumour microenvironment. Recent studies identified subtypes based on the total RNA present in the tumours. Here, specific grouped genes in tumour and stroma cells identified two epithelial subtypes: the 'basal-like' and 'classical', and two stroma subtypes: 'mature/normal' and 'immature/activated'. The differing impact on disease progression may be due to difference in communication. The availability of these molecules depends on various factors, including the level of gene expression and processing by a protein called a protease. Their role in breaking down their molecular targets highlights the importance of proteases in regulating cell-to-cell communication. My project aims to investigate the differential expression of proteases at the subtype level. Using various datasets to quantify different levels of gene expression, first, I will define a shortlist of proteases with clear prognostic impact using computational means. This will be validated in tissues by quantifying protease expression. Our lab has created a workflow that allows semi-automated quantification of the level of staining in an image, and interrogation and visualization of our results. Second, experimental models will be used to address which of the candidate proteases are potential therapeutic targets; these models include growing tumour and stroma cells together and using patient-derived 3D culture systems. Identifying the proteases that differ between subtypes can bring to light new therapies for PDAC. Furthermore, my computational analysis will create a protease-resource for other studies to utilize and potentially find more candidates for future therapies.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
449637
Name
Vyas Foram
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Unraveling targetable protease networks in tumour and stroma subtypes of pancreatic cancer
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Cancer-Associated Fibroblast; Disease Progression; Pancreatic Cancer; Pancreatic Cancer Organoids; Protease; Proteome; Single-Cell Rna-Sequencing; Transcriptome; Tumour Microenvironment
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer. One major characteristic of PDAC is the stroma, or the tumour microenvironment. Recent studies identified subtypes based on the total RNA present in the tumours. Here, specific grouped genes in tumour and stroma cells identified two epithelial subtypes: the 'basal-like' and 'classical', and two stroma subtypes: 'mature/normal' and 'immature/activated'. The differing impact on disease progression may be due to difference in communication. The availability of these molecules depends on various factors, including the level of gene expression and processing by a protein called a protease. Their role in breaking down their molecular targets highlights the importance of proteases in regulating cell-to-cell communication. My project aims to investigate the differential expression of proteases at the subtype level. Using various datasets to quantify different levels of gene expression, first, I will define a shortlist of proteases with clear prognostic impact using computational means. This will be validated in tissues by quantifying protease expression. Our lab has created a workflow that allows semi-automated quantification of the level of staining in an image, and interrogation and visualization of our results. Second, experimental models will be used to address which of the candidate proteases are potential therapeutic targets; these models include growing tumour and stroma cells together and using patient-derived 3D culture systems. Identifying the proteases that differ between subtypes can bring to light new therapies for PDAC. Furthermore, my computational analysis will create a protease-resource for other studies to utilize and potentially find more candidates for future therapies.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Vyas, Foram
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~